Home › News › Pharma Industry News › Archive

Pharmaceutical Industry News Archive

Get news By email or subscribe to our News feeds.

All News Consumer Pharma New Drugs Pipeline Clinical Trials

February 2007

February 1

AstraZeneca Acquires Arrow Therapeutics To Broaden Anti-Infective Capabilities AstraZeneca PLC - Fourth Quarter and Full Year Results 2006 Court Rules In Pfizer's Favor In Norvasc Patent Case, Finds Synthon Obtained Patent By Inequitable Conduct Fresenius Medical Care and Amgen Enter New Commercial Collaboration in Europe Fresenius Medical Care and Amgen Establish a Joint Research Program in Europe FDA Sends MGI Pharma Letter Over Gliadel Wafer Advertisement Ligand Announces Corporate Restructuring Conor Medsystems Stockholders Approve Merger Agreement with Johnson & Johnson Strides Arcolab's JV acquires Farma Plus, Norway Intellect Neurosciences, Inc. Converts into a Public Company Through Merger Transaction with GlobePan Resources, Inc. Alembic Acquires Non-Oncology Business of Dabur Pharma Ltd. Pfizer to Acquire BioRexis to Access Novel Technology Platform and Early Stage Diabetes Pipeline FDA Announces Important Changes to Fuzeon Product Labeling Astellas Will Offer an Early Retirement Program to Japanese Employees Grifols Announces FDA Approval of Alphanate to Treat von Willebrand Disease EaglePicher Pharmaceutical Services Acquired by Aptuit Hospira Completes Acquisition of Mayne Pharma, Announces New Commercial Leadership Structure

February 2

Numira Biosciences and Visual Influence Announce Merger Eli Lilly Japan and Shionogi to Co-Develop and Co-Market Duloxetine in Japan GlaxoSmithKline Receives Approvable Letter for New Indications for Arixtra (Fondaparinux Sodium) Injection Accelrys Announces Pfizer Inc. as the First Member of the Enterprise Cheminformatics Consortium CSL Behring and Bayer Extend Agreement for Supply of Helixate Recombinant Coagulation Factor Texas Hormone Therapy Lawsuit Has Been Dismissed Anacor Signs Worldwide Exclusive License Agreement With Schering-Plough for AN2690, a New Topical Anti-Fungal Treatment GTx's Phase III Clinical Development of Acapodene on Course Following Planned Safety Review FDA MedWatch - Lucentis (ranibizumab injection) - Preliminary Safety Information From a Planned Interim Analysis In an On-Going Study (SAILOR Study) China Health Holding Acquires Majority Stake in Beijing Boran Pharmaceutical Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals Valtrex (valacyclovir) - US Patent Litigation Update Mitsubishi Pharma Corporation Reaches a Basic Agreement to Merge with Tanabe Seiyaku Co., Ltd. FDA Approves New Dosing Recommendations for Rapamune in High Immunologic Risk Renal Transplant Patients All Global is Acquired by WPP Common Blood Pressure Drug Reduces Progressive Muscle Degeneration in Mice

February 5

Arena Pharmaceuticals Completes Enrollment with 3,182 Patients in Lorcaserin Phase 3 Trial for Obesity Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies AstraZeneca Licenses Regeneron's VelocImmune Technology for Discovering Human Monoclonal Antibodies ImClone Systems Incorporated and Bristol-Myers Squibb Announce Application In Japan for Use of Erbitux in Metastatic Colorectal Cancer Roche Continues to Strengthen Research and Development Focus on Disease Biology Areas to Enhance Alignment of R&D elbion and Wyeth Enter Collaboration to Develop New Treatments for Schizophrenia UTEK Corporation and CytoDyn, Inc. Complete Technology Transfer Impax Files Revised Submission with Office of the Chief Accountant of the SEC Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women with a Previous Preterm Birth Earlier than 35 Weeks Does Not Meet Endpoints Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies AXM Pharma Announces Acquisition of Leading Chinese Research Institute Mitsubishi Chemical Holdings: Business Results for the Third Quarter of the Fiscal Year Ending March 31, 2007 President’s FY 2008 Budget Advances FDA’s Public Health Goals, Including Improving Safety of Nation’s Food Supply

February 6

ImClone Systems Opts-out of Development Agreement with UCB to Focus Resources on Proprietary, Anti-VEGFr-2 Antibody IMC-1121B ViaCell Announces CB001 Phase I Results KineMed and Bayer Healthcare AG Enter Collaboration to Discover New Therapeutic Applications for Drug Candidates Migenix Provides Update on License-Option Agreement with Schering-Plough for Celgosivir in Hepatitis C Eisai Confirms Application for Judicial Review of NICE Laureate Pharma Announces Collaboration With Boehringer Ingelheim Genta Announces the Company Will Appeal FDA Action on New Drug Application of Genasense in Chronic Lymphocytic Leukemia UCB Gains Global Rights Pertaining to VEGFR-2 for CDP-791 Global Agreement for HuMax-CD20 Receives Antitrust Clearance Abbott to Initiate First Study to Evaluate Xience V Everolimus Eluting Coronary Stent System in Treatment of Women with Cardiovascular Disease WEHI Enters Research Collaboration With Genentech to Develop New Cancer Drugs Ranbaxy Signs a New R&D Agreement with GSK Orion Updates Progress with Simdax (i.v. levosimendan) Jerini Expands Collaboration with Baxter to Develop Non-intraveneous Hemophilia Therapy Abbott Statement Regarding CMS' Proposed Expansion of Coverage for Carotid Artery Stenting Bio-Imaging Completes the Acquisition of Theralys SA of Lyon, France Strategic Planning for Discovery, Development and Clinical Operations in China, India and other Emerging Regions

February 7

Forest Laboratories Announces Termination of Agreement for Faropenem Roche Posts Outstanding Results for 2006 FDA Public Health Advisory: Life-Threatening Side Effects with the Use of Skin Products Containing Numbing Ingredients for Cosmetic Procedures Drug Used in Coronary Artery Bypass Graft Surgery May Increase Risk of Death Return on Investment for Pediatric Exclusivity Program Varies Widely for Pharmaceutical Companies Inex Pharmaceuticals Announces Court of Appeal Win Replidyne and Forest End Faropenem Collaboration Baxter Receives Clearance From U.S. FDA for Ipump Pain Management System 510(k) Bayer Responds to Study and Commentary Published in Journal of American Medical Association Cambrex Completes Sale of Bio Businesses Celtic Pharma Terminates Transmid Trial KSB311R/CIII/001 GlaxoSmithKline Accepts Shares in Tender Offer for Shares of Praecis Pharmaceuticals and Commences Subsequent Offering Period IACP Calls on NAMS to Disclose Financial Ties to Wyeth New Analysis Shows That Intensive Lipitor Therapy Cuts the Risk of Hospitalizations Due to Heart Failure in Patients with Coronary Heart Disease Polydex Pharmaceuticals Issues Interim Report on Business Operations CDC, FAA, NIH, FDA, FBI and USDA Get the Highest Ratings of Thirteen Federal Government Agencies

February 8

FDA Approves Orlistat for Over-the-Counter Use Centocor, Inc. Releases Phase 2 Data on Novel Biologic CNTO 1275 Targeting Chronic Plaque Psoriasis Glaxosmithkline and Fabre-Kramer Pharmaceuticals Enter Global Agreement for New Treatment of Major Depressive Disorder Baxter Continues Collaborations With Global Health Authorities to Advance Pandemic Preparedness Daiichi Sankyo Returns Development Rights of KAI-9803 FDA Approves alli (orlistat 60 mg capsules) Over-The-Counter Standard Therapy More Effective Than Diabetes Drug for Achieving Pregnancy in Common Fertility Disorder GlaxoSmithKline Delivers Strong 2006 Performance with Full Year EPS Up 19% CER (16% Reported) SEC Charges Family With a $3.7 Million Insider Trading Scheme Pfizer's Sutent Receives FDA Approval to Include New First-Line Advanced Kidney Cancer Data in Label

February 12

NicOx Presents Promising Pre-Clinical Results on an NO-Donating Latanoprost Derivative From Its Glaucoma Collaboration With Pfizer Watson and GlaxoSmithKline Settle Lawsuit Over Wellbutrin Xl Adeza to Be Acquired by Cytyc for $24 Per Share AIDS Healthcare Foundation Bans Pfizer’s Drug Reps From Its Clinics Nexavar Shown to Significantly Extend Survival for Patients with Advanced Liver Cancer Forbes Medi-Tech Announces Next Steps in Pharmaceutical Development and Corporate Restructuring New Campaign Champions Changes in Medical Prescribing to End Conflicts of Interest Cell Therapeutics, Inc. Spin-off to Use Proprietary Recombinant Genetic Technology to Develop Novel Biopharmaceuticals FDA Announces Label and Indication Changes for the Antibiotic Ketek Sanofi-Aventis Announces Update to U.S. Prescribing Information for Ketek (Telithromycin) Commonwealth Biotechnologies, Inc. Completes Acquisition of Mimotopes Pty Ltd Ranbaxy Launches Atorvastatin in Denmark

February 13

Multiple Articles in the New England Journal of Medicine Confirm On-Label, Long-Term Safety and Efficacy of the Cypher Sirolimus-Eluting Coronary Stent Compared to Bare Metal Stents Boston Scientific Welcomes New England Journal of Medicine Articles on Drug-Eluting Stents Johnson & Johnson Statement on Voluntary Disclosure Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and Europe Sanofi-aventis 2006: In a Difficult Environment, Another Year of Growth in Adjusted EPS Excluding Selected Items Teva Reports Fourth Quarter and Full Year 2006 Results Novartis, The Broad Institute, and Lund University Announce Release of Genome-wide Analysis of Genes Associated with Type 2 Diabetes and Related Metabolic Disorders Organon and Pharmacopeia Enter Into Discovery, Development and Commercialization Alliance Ingenuity Systems Announces Extension and Expansion of its Licensing Agreement with Merck ChemDiv to Provide Merck KGaA With Discovery Chemistry in Multiyear Agreement, Extending Ongoing Collaboration Generic Anti-Cholesterol Drugs Save $126 Million for Plan Sponsors, Patients Three Companies Consolidate under Holding Company Prescriptions for Cholesterol Drugs Rise with New Generics

February 14

Study Published in The New England Journal of Medicine: 55 Percent Fewer Cases of Flu in Young Children Vaccinated With FluMist Vs. Flu Shot Merck Updates Prescribing Information for Rotateq, the Company's Vaccine to Help Prevent Rotavirus Gastroenteritis in Infants and Children Favrille Announces Agreement With Berlex, Inc. Regarding Use of FavId in Combination With Leukine (sargramostim) in B-Cell Non-Hodgkin's Lymphoma Halozyme And Baxter Expand Global Hylenex Collaboration Daiichi Sankyo Announces Midterm Management Plan for Fiscal 2007-2009 Dainippon Sumitomo Pharma Co., Ltd.:Launch of 'Replagal 3.5 mg' for Anderson-Fabry Disease Genzyme Reports Financial Results for Fourth Quarter of 2006 and Full Year Merck Settles Tax Dispute with Internal Revenue Service Advancis Pharmaceutical Announces FDA Decision That its Amoxicillin Pulsys NDA is Not Complete Telik Announces Corporate Restructuring Biovail Issues Statement on Reports of Conclusion of SEC Gradient Investigation Eli Lilly and Company Statement: Judge Grants Lilly's Request for a Permanent Injunction Involving Misleading Selection of Illegally Leaked Lilly Documents Abraxis Bioscience Completes Acquisition of Manufacturing Complex from Pfizer Merck & Co., Inc., Again Reduces Price of Stocrin (efavirenz) for Patients in Least Developed Countries and Countries Hardest Hit by Epidemic

February 16

FDA Alerts Consumers to Unsafe, Misrepresented Drugs Purchased Over the Internet Ranbaxy: Press Statement Wyeth Wins Little Rock Hormone Therapy Trial GPC Biotech Submits NDA for Lead Oncology Drug Candidate Satraplatin Closing of Boehringer Ingelheim`s Divestiture of Pharmaton SA to Ideasphere Cancelled First and Only Treatment Now Available for Mild-to-Moderate Parkinson's Disease Dementia Roche Files Application in Europe for Tamiflu 30 and 45 Mg Capsules GlaxoSmithKline Successfully Completes Tender Offer for Shares of Praecis Pharmaceuticals Advanced Magnetics Announces Settlement of Lawsuit with Cytogen Corporation InSite Vision Announces Patent Agreement With Pfizer Inspire Licenses AzaSite For Ocular Infections European Approval of HIV Drug darunavir Will Provide a Potent New Option With Fuzeon for Treatment-Experienced Patients Anti-HIV Medication Prezista Receives Conditional Marketing Authorisation in the European Union FDA Sends Abraxis BioScience Warning Letter Over Manufacturing Problems

February 20

Shire plc: On Time Execution of Operating Plan Delivers Strong 2006 Performance Shire Agrees to Acquire New River to Gain Full Control of Vyvanse, its Future Flagship Product for ADHD New River Pharmaceuticals to be Acquired by Shire plc for $64 Per Share Shire Announces US$800 Million Equity Financing in Connection With Acquisition of New River New AARP Poll Shows 86% of Americans Over 18 Believe Medicare Should Have Bargaining Power for Prescription Drugs Bristol-Myers Squibb Completes Land Acquisition for New Biologics Facility SAFE Standard and Arcot Software Used By AstraZeneca to Submit First Digitally Signed Submission to FDA Entelos and Organon Extend Research Agreement Cancer Drug Can Extend Survival in Patients with Deadly Brain Tumors MIV Therapeutics Completes Acquisition of Biosync Scientific to Expand Operations and Accelerate Commercialization in Fast-Growing Markets Philadelphia Hormone Therapy Trial Completed Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc. Plaintiffs Win Another Prempro Case in Philadelphia; Wyeth Loses Second Hormone Therapy Drug Case FDA Warns About Erythropoiesis Stimulating Agents (ESAs) - Results of Aranesp Study May Apply to Other ESAs

February 21

Pharmacyclics Receives Refuse to File Letter for Xcytrin King Pharmaceuticals Announces FDA Approval of New Bicillin Manufacturing Facility TransTech Pharma, Inc. Obtains Exclusive License to Glucokinase Activator Program for the Treatment of Diabetes from Novo Nordisk New Storage Instructions Approved for Byetta CSL Ltd.: Interim Result - Strong Profit from Operations, Up 46% to $257 Million Dyax and Genzyme Announce Agreement to Terminate Joint Venture for the Commercialization of DX-88 in HAE Vaccine Safety Group Releases Gardasil Reaction Report Merck KGaA: Karl-Ludwig Kley to Succeed Michael Roemer as Chairman of the Executive Board Access Pharmaceuticals Signs Letter of Intent to Acquire Somanta Pharmaceuticals Comprehensive Company, Brand, and Pipeline Database Now Provides Company-wide Access GlaxoSmithKline Advises Health Officials on Avandia PCMA: PBMs Negotiating Lower Drug Prices in Medicare Part D FDA Proposes to Strengthen Label Warning for Xolair FDA Directs ADHD Drug Manufacturers to Notify Patients about Cardiovascular Adverse Events and Psychiatric Adverse Events Though Most Physicians Support a Ban on Collecting Prescribing Information, Only a Fraction Have Used PDRP to Restrict Rx Data Access FDA MedWatch: Xolair (omalizumab) New Reports of Serious and Life-Threatening Allergic Reactions (anaphylaxis) Pennsylvania Attorney General Corbett Recovers $7.8 Million in Settlement Funds for State's Medicaid Program

February 22

Lilly Introduces World's First Digital Insulin Pen With Memory Emergent BioSolutions Remains Committed to Development of Enhanced Anthrax Countermeasures AstraZeneca Announces Investment in $120m Laboratory for Process Research and Development at its Macclesfield Site, Cheshire, UK Sartorius AG Combines its Biotechnology Division with Stedim Biosystems S.A. and Becomes the Majority Owner of the Combined Entity Analysis of International Phase III Study of Avastin Plus Chemotherapy Shows Improved Progression-Free Survival in Patients With Advanced Lung Cancer Entelos Announces Continued Research with Pfizer Ark Wins Key Patent Case on Stroke in Europe Survey Shows Supreme Court Ruling May Hinder IP Licensing Lilly Introduces World's First Digital Insulin Pen With Memory Pharmaceutical Consumers & Marketers Surveyed to Assess Perceptions of Direct-to-Consumer Advertising in the Post-Vioxx Era Arpida Realigns Activities to Support Transition of Its Research Portfolio Ikaria and Investor Group to Acquire INO Therapeutics in $670 Million Cash and Stock Merger, Creating a World Leader in Critical Care Therapeutics Express Scripts and PCMA Follow-On Biologics Studies Are Based on Flawed Assumptions That Undermine Their Credibility: BIO Analysis Raises Serious Concerns Over Two Cost Savings Studies

February 26

FDA Approves Cymbalta for Treatment of Generalized Anxiety Disorder Shire and New River Pharmaceuticals Announce FDA Approval of the First and Only Stimulant Prodrug Vyvanse (lisdexamfetamine dimesylate) as a Novel Treatment for ADHD Avalon Pharmaceuticals Announces the Initiation of the Primary Screening Phase in Drug Discovery Collaboration Novartis Committed to Making Galvus Available for Patients with Type 2 Diabetes After US Regulators Issue ''Approvable Letter'' Lilly Plans New Clinical Trial of Xigris Drug Industry Increasingly Influences Breast Cancer Research FDA MedWatch: Baraclude Risk of Developing HIV Resistance Cannot be Excluded When Used in an HIV/HBV Co-infected Patient Not Receiving HAART Epix Reports Intention to Restate Financial Statements for Prior Fiscal Periods Inex Provides Timeline for Completing Spin-out of Tekmira Pharmaceuticals Corporation Graffinity and Amgen Enter into Drug Discovery Research Agreement Bristol-Myers Squibb Company and Adnexus Therapeutics Announce Collaboration to Develop and Commercialize Innovative Oncology Compounds Shire Extends Fosrenol | at Hand Program to Cover Medicare Part D Enrollees Azur Pharma Announces the Acquisition of Pharmelle GSK Initiates First Global Phase III Study of Tykerb (lapatinib) in Head and Neck Cancer Positive Recommendation for Avastin Use in Advanced or Recurrent Colorectal Cancer in Japan Phase 3 Stroke Trial Shows That Novoseven Reduces Bleeding in the Brain, but Does Not Improve Long-term Clinical Outcomes Takeda and TAP to Promote Sucampo's Amitiza in the United States BD Biosciences and Roche Collaborate to Advance the Study of Cell Signal Transduction through New Phosphorylation Site Antibody Targets and Applications VGX Pharmaceuticals and ADViSYS Announce Merger Agreement: Creation of VGX Immune Therapeutics Division Inex Pharmaceuticals Submits Petition Against Protiva Biotherapeutics

February 27

Post-Hoc Data Analyses Published in Annals of Neurology Found Copaxone Significantly Delayed Accumulated Disability in Male Patients with Primary Progressive Multiple Sclerosis (PPMS) Vaccinex Announces Antibody Development and Commercialization Alliance in Multiple Sclerosis and Oncology Unigene Achieves $5.5 Million Milestone in Calcitonin Collaboration for Phase III Initiation inVentiv Health to Acquire Ignite Health, Leading Technology-Driven Healthcare Ad Agency Threshold Pharmaceuticals Announces That a Phase 3 Clinical Trial of Glufosfamide for Treatment of Pancreatic Cancer Did Not Meet Its Primary Endpoint Judgments Granted in Favor of Chugai in Lawsuits Filed by Ajinomoto Co., Inc. Increased Prescription Drug Co-pays Linked to Lower Medication Usage and Higher Hospitalization Rates, Thomson Medstat Study Finds AdMedia Partners Advises Ignite Health, an Interactive Healthcare Marketing Agency, in Acquisition by inVentiv Health More than 300 Medicines Now in Development to Treat Rare Diseases Mylan Provides an Update on Amlodipine Besylate Litigation FDA Approves New Treatment For Crohn's Disease Humira (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease Pfizer Wins Challenge to Norvasc Patent by Mylan

February 28

FDA Approves First Drug To Prevent and Treat Vomiting in Dogs Merck Announces First Quarter Earnings Per Share Guidance and Raises Full-Year 2007 Earnings Per Share Guidance Avanir Pharmaceuticals Summarizes Outcome of FDA Meeting on Zenvia NDA American Heart Association Scientific Statement: AHA Statement Recommends Doctors Change Approach to Prescribing Pain Relievers for Patients With or at Risk for Heart Disease Epix Pharmaceuticals Files Formal Appeal for Vasovist with the Center for Drug Evaluation and Research Xoma Announces Expiration of Oncology Exclusivity Obligation With Novartis Barr Reports GAAP Loss For Three and Six Months Ended December 31, 2006 of $3.67 Per Share and $3.18 Per Share; Adjusted Earnings For Three and Six Months Were $0.83 Per Share and $1.70 Per Share Alnylam Scientist Awarded Two Industry Honors Daiichi Pharmaceutical (Beijing) Granted Sales Promotion Permission Novo Nordisk Divests Its Ownership of Dako's Business Activities King Pharmaceuticals Reports Year-End and Fourth-Quarter 2006 Financial Results UCB Full-Year 2006 Financial Results Salix Pharmaceuticals Acquires Pepcid Oral Suspension HPV Infection Common Among Females in U.S. Mylan Announces Launch of Quinapril Tablets, USP and Quinapril Hydrochloride and Hydrochlorothiazide Tablets King Pharmaceuticals Announces FDA Approval of Altace Tablet Formulation New Study: 'Show Me the Savings'

Pharmaceutical Industry News Archive

More News Resources

Printable Version Email Recommend Tweet Save or Share
(web3)